Preview

Meditsinskiy sovet = Medical Council

Advanced search
Fullscreen

For citations:


Menshikov KV, Sultanbaev AV, Musin SI, Izmailov AA, Chalov VS, Menshikova IA, Sultanbaeva NI, Popova EV, Lipatov DO. Efficacy of the 1st generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens. Meditsinskiy sovet = Medical Council. 2022;(9):85-92. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-9-85-92

Views PDF (Rus): 156


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)